Navigation Links
MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015

DALLAS, July 14, 2010 /PRNewswire/ -- According to a new market research report, 'Patient Monitoring Devices - Emerging Markets BRIC (Brazil, Russia, India and China) 2010-2015, published by MarketsandMarkets (, the BRIC patient monitoring market is expected to be worth $2,992 million by 2015, with China accounting for nearly 62.9% of the total revenues.

Browse in-depth TOC on Patient Monitoring Market. Early buyers will receive 10% customization of reports

This market research report categorizes the BRIC patient monitor devices market as per their usage in emergency rooms, critical care units, and intensive care units. The devices analyzed are patient monitors, vital signs monitors, fetal monitors, anesthesia monitors, neonatal monitors, and central station monitors. The major players in the overall market include Philips Healthcare, Netherlands, Schiller AG, Switzerland, Mindray Medical International Ltd., China.


The report analyzes the BRIC patient monitoring market on following parameters:

    - Which are the high growth segments in the patient monitoring
      markets of Brazil, Russia, India, and China?

    - What are market estimates and forecasts; which are markets are
      doing well and which are not?

    - What is the competitive outlook; who are the main players in each
      segment; what are the key-selling products; what are their strategic
      directives, operational strength and product pipelines? Who is doing

Analyst Briefing Presentation on the Patient Monitoring Devices - Emerging Markets BRIC (Brazil, Russia, India, China) 2010-2015 to be held on 29th July 2010

The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Patient Monitoring Devices - Emerging Markets BRIC (Brazil, Russia, India, China) 2010-2015 ( to be held on 29th July 2010.

(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

To register your participation, please click here:

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website

    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets: Healthcare Information Technology Systems Market to be Worth $53.8 Billion by 2014
2. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
3. Group Practice Forum Launches Fromer-GPF Patient Journey Providing Physicians with Simple Solutions to Improve Patient Care
4. New Report Patient Monitoring Emerging Markets (BRIC - Brazil, Russia, India and China) 2010 - 2014 Published by MarketsandMarkets
5. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
6. Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
7. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
8. Appellate Court Sides With Terminally-Ill Medical Marijuana Patient
9. InteKrin Therapeutics Presented Phase 2b Clinical Data at the 2010 American Diabetes Association Annual Meeting, Demonstrating Improved Glycemic Control in Patients with Type 2 Diabetes Without Causing the Edema Seen with Pioglitazone
10. Study Shows Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients
11. Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
Post Your Comments:
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, ... more than $100 billion in purchasing power, today announced ... and information. The Newsroom is the online ... industry trends, infographics, expert bios, news releases, slideshows and ... access to a wealth of resources at their fingertips, ...
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):